142 related articles for article (PubMed ID: 11954048)
1. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
Carta AR; Pinna A; Cauli O; Morelli M
Synapse; 2002 Jun; 44(3):166-74. PubMed ID: 11954048
[TBL] [Abstract][Full Text] [Related]
2. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
Pinna A; Fenu S; Morelli M
Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
Cenci MA; Lee CS; Björklund A
Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
[TBL] [Abstract][Full Text] [Related]
4. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates.
Laprade N; Soghomonian JJ
Synapse; 1999 Jul; 33(1):36-48. PubMed ID: 10380849
[TBL] [Abstract][Full Text] [Related]
6. Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
Pinna A; Fenu S; Morelli M
Synapse; 2001 Mar; 39(2):233-238. PubMed ID: 11169767
[TBL] [Abstract][Full Text] [Related]
7. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
Wardas J; Konieczny J; Lorenc-Koci E
Synapse; 2001 Aug; 41(2):160-71. PubMed ID: 11400182
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
Fenu S; Pinna A; Ongini E; Morelli M
Eur J Pharmacol; 1997 Feb; 321(2):143-7. PubMed ID: 9063681
[TBL] [Abstract][Full Text] [Related]
9. Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease.
Carta A; Fenu S; Morelli M
Neurol Sci; 2001 Feb; 22(1):59-60. PubMed ID: 11487201
[TBL] [Abstract][Full Text] [Related]
10. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
Johansson PA; Andersson M; Andersson KE; Cenci MA
Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.
Yamamoto N; Soghomonian JJ
Neuroscience; 2009 Nov; 163(4):1171-80. PubMed ID: 19660528
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats.
Chang WY; Webster RA
Br J Pharmacol; 1997 May; 121(2):331-7. PubMed ID: 9154345
[TBL] [Abstract][Full Text] [Related]
13. Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.
Popoli P; Reggio R; Pèzzola A
Neuropsychopharmacology; 2000 May; 22(5):522-9. PubMed ID: 10731627
[TBL] [Abstract][Full Text] [Related]
14. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
Mura A; Feldon J; Mintz M
Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
[TBL] [Abstract][Full Text] [Related]
15. Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats.
Consolo S; Morelli M; Rimoldi M; Giorgi S; Di Chiara G
Neuroscience; 1999; 89(4):1183-7. PubMed ID: 10362306
[TBL] [Abstract][Full Text] [Related]
16. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
Sivam SP; Krause JE
J Pharmacol Exp Ther; 1990 Aug; 254(2):433-9. PubMed ID: 1696630
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.
Westin JE; Vercammen L; Strome EM; Konradi C; Cenci MA
Biol Psychiatry; 2007 Oct; 62(7):800-10. PubMed ID: 17662258
[TBL] [Abstract][Full Text] [Related]
18. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
[TBL] [Abstract][Full Text] [Related]
19. Does adenosine receptor blockade mediate caffeine-induced rotational behavior?
Garrett BE; Holtzman SG
J Pharmacol Exp Ther; 1995 Jul; 274(1):207-14. PubMed ID: 7616401
[TBL] [Abstract][Full Text] [Related]
20. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment.
Cenci MA; Tranberg A; Andersson M; Hilbertson A
Neuroscience; 1999; 94(2):515-27. PubMed ID: 10579213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]